Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST StudyHideki Ueno, Masao Tanaka, T Shimamura et al.|Journal of Clinical Oncology|2013Cited by 632
Clinical practice guidelines for the management of biliary tract cancers 2015: the 2<sup>nd</sup> English editionMasaru Miyazaki, Tadahiro Takada, Hideyuki Yoshitomi et al.|Journal of Hepato-Biliary-Pancreatic Sciences|2015Cited by 300
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall SurvivalYu Sawada, Tetsuya Nakatsura, Toshiaki Yoshikawa et al.|Clinical Cancer Research|2012Cited by 299
Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinomaReiko Takayama, Kenji Yamao, Hidewaki Nakagawa et al.|Journal of Gastroenterology|2009Cited by 56
Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer.Yuji Kobayashi, Kenji Yamao, Keitaro Matsuo et al.|PubMed|2011Cited by 16